Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12306)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 28, 2016 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Fotbolcu H, Zorlu E. Nonalcoholic fatty liver disease as a multi-systemic disease. World J Gastroenterol 2016; 22(16): 4079-4090 [PMID: 27122660 DOI: 10.3748/wjg.v22.i16.4079] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i16/4079.htm |
| Number | Citing Articles |
| 1 |
Gökay Taylan, Mustafa Ebik, Serdar Solak, Çağlar Kaya, Kenan Yalta. Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver disease. Revista da Associação Médica Brasileira 2022; 68(10): 1428 doi: 10.1590/1806-9282.20220514
|
| 2 |
Masafumi Takae, Koichiro Fujisue, Eiichiro Yamamoto, Koichi Egashira, Takashi Komorita, Fumi Oike, Taiki Nishihara, Masahiro Yamamoto, Kyoko Hirakawa, Noriaki Tabata, Takanori Tokitsu, Kenshi Yamanaga, Daisuke Sueta, Shinsuke Hanatani, Taishi Nakamura, Hiroki Usuku, Satoshi Araki, Yuichiro Arima, Seiji Takashio, Satoru Suzuki, Koichi Kaikita, Kenichi Matsushita, Kenichi Tsujita. Prognostic significance of liver stiffness assessed by fibrosis‐4 index in patients with heart failure. ESC Heart Failure 2021; 8(5): 3809 doi: 10.1002/ehf2.13351
|
| 3 |
Daniel A. Montes-Galindo, Ana C. Espiritu-Mojarro, Valery Melnikov, Norma A. Moy-López, Alejandro D. Soriano-Hernandez, Hector R. Galvan-Salazar, Jorge Guzman-Muñiz, Jose Guzman-Esquivel, Margarita L. Martinez-Fierro, Iram P. Rodriguez-Sanchez, Brenda Paz-Michel, Sergio A. Zaizar-Fregoso, Carmen A. Sanchez-Ramirez, Mario Ramirez-Flores, Ivan Delgado-Enciso. Adenovirus 5 produces obesity and adverse metabolic, morphological, and functional changes in the long term in animals fed a balanced diet or a high-fat diet: a study on hamsters. Archives of Virology 2019; 164(3): 775 doi: 10.1007/s00705-018-04132-6
|
| 4 |
Francesca Oppedisano, Carolina Muscoli, Vincenzo Musolino, Cristina Carresi, Roberta Macrì, Caterina Giancotta, Francesca Bosco, Jessica Maiuolo, Federica Scarano, Sara Paone, Saverio Nucera, Maria Caterina Zito, Miriam Scicchitano, Stefano Ruga, Monica Ragusa, Ernesto Palma, Annamaria Tavernese, Rocco Mollace, Ezio Bombardelli, Vincenzo Mollace. The Protective Effect of Cynara Cardunculus Extract in Diet-Induced NAFLD: Involvement of OCTN1 and OCTN2 Transporter Subfamily. Nutrients 2020; 12(5): 1435 doi: 10.3390/nu12051435
|
| 5 |
Xiaoya Zheng, Wei Ren, Lilin Gong, Jian Long, Rong Luo, Yonghong Wang. The Great Chinese Famine Exposure in Early Life and the Risk of Nonalcoholic Fatty Liver Disease in Adult Women. Annals of Hepatology 2017; 16(6): 901 doi: 10.5604/01.3001.0010.5281
|
| 6 |
Yingchun Wang, Juan Chen, Weizong Kong, Ruiping Zhu, Kai Liang, Quanxiang Kan, Yanhong Lou, Xiangyu Liu. Regulation of SIRT3/FOXO1 Signaling Pathway in Rats with Non-alcoholic Steatohepatitis by Salvianolic Acid B. Archives of Medical Research 2017; 48(6): 506 doi: 10.1016/j.arcmed.2017.11.016
|
| 7 |
Laura S. Chiu, Alison Pedley, Joseph M. Massaro, Emelia J. Benjamin, Gary F. Mitchell, David D. McManus, Jayashri Aragam, Ramachandran S. Vasan, Susan Cheng, Michelle T. Long. The association of non‐alcoholic fatty liver disease and cardiac structure and function—Framingham Heart Study. Liver International 2020; 40(10): 2445 doi: 10.1111/liv.14600
|
| 8 |
Athanasia Mitsala, Christos Tsalikidis, Konstantinos Romanidis, Michail Pitiakoudis. Non-Alcoholic Fatty Liver Disease and Extrahepatic Cancers: A Wolf in Sheep’s Clothing?. Current Oncology 2022; 29(7): 4478 doi: 10.3390/curroncol29070356
|
| 9 |
Hamza El Hadi, Angelo Di Vincenzo, Roberto Vettor, Marco Rossato. Relationship between Heart Disease and Liver Disease: A Two-Way Street. Cells 2020; 9(3): 567 doi: 10.3390/cells9030567
|
| 10 |
S. V. Okovity, K. L. Raikhelson, A. V. Volnukhin, D. A. Kudlai. Hepatoprotective properties of glycyrrhizic acid. Experimental and Clinical Gastroenterology 2020; (12): 96 doi: 10.31146/1682-8658-ecg-184-12-96-108
|
| 11 |
Stefan Schreier, Wannapong Triampo. Systemic cytology. A novel diagnostic approach for assessment of early systemic disease. Medical Hypotheses 2021; 156: 110682 doi: 10.1016/j.mehy.2021.110682
|
| 12 |
Sima Golmohammadi, Marjan Tavasoli, Nadia Asadi. <p>Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver</p>. Clinical and Experimental Gastroenterology 2020; : 299 doi: 10.2147/CEG.S253619
|
| 13 |
Kei Tokutsu, Kaoru Ito, Shigeki Kawazoe, Sota Minami, Kenji Fujimoto, Keiji Muramatsu, Shinya Matsuda. Clinical characteristics in patients with non-alcoholic steatohepatitis in Japan: a case–control study using a 5-year large-scale claims database. BMJ Open 2023; 13(8): e074851 doi: 10.1136/bmjopen-2023-074851
|
| 14 |
Ananya Chakravorty, Samuel J. White, Ivan B. Ye, Zoe B. Cheung, Samuel Kang-Wook Cho. Effects of Underlying Liver Disease on 30-Day Outcomes After Posterior Lumbar Fusion. World Neurosurgery 2019; 125: e711 doi: 10.1016/j.wneu.2019.01.160
|
| 15 |
Uriel A. López-Lemus, Raquel Garza-Guajardo, Oralia Barboza-Quintana, Alejandrina Rodríguez-Hernandez, Alejandro García-Rivera, Violeta M. Madrigal-Pérez, José Guzmán-Esquivel, Laura E. García-Labastida, Alejandro D. Soriano-Hernández, Margarita L. Martínez-Fierro, Iram P. Rodríguez-Sánchez, Elizabeth Sánchez-Duarte, Ariana Cabrera-Licona, Gabriel Ceja-Espiritu, Iván Delgado-Enciso. Association Between Nonalcoholic Fatty Liver Disease and Severe Male Reproductive Organ Impairment (Germinal Epithelial Loss): Study on a Mouse Model and on Human Patients. American Journal of Men's Health 2018; 12(3): 639 doi: 10.1177/1557988318763631
|
| 16 |
Sahar Y. Al-Okbi, Doha A. Mohamed, Eman E. Abd-Elhady, Ahmed M.S. Hussein, Enas S.K. Al-Siedy. Comparative Study of Orange and its Main Bioactive Constituents as Remedy for Non-alcoholic Fatty Liver in Rats. Pakistan Journal of Biological Sciences 2018; 21(7): 359 doi: 10.3923/pjbs.2018.359.368
|
| 17 |
Ludovico Abenavoli, Natasa Milic, Laura Di Renzo, Tomislav Preveden, Milica Medić-Stojanoska, Antonino De Lorenzo. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(31): 7006-7016 doi: 10.3748/wjg.v22.i31.7006
|
| 18 |
Asad Mirzaei, Asma Asal, Ali Seidkhani-Nahal, Ali Noori-Zadeh. A systematic review and meta-analysis of serum resistin level and its relation to HOMA-IR score using meta-regression in nonalcoholic fatty liver disease patients. Mediterranean Journal of Nutrition and Metabolism 2021; 14(3): 219 doi: 10.3233/MNM-210538
|
| 19 |
Narendra S. Choudhary, Neeraj Saraf, Sanjiv Saigal, Ajay Duseja, Dheeraj Gautam, Amit Rastogi, Prashant Bhangui, Srinivasan Thiagrajan, Arvinder S. Soin. Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors. Journal of Clinical and Experimental Hepatology 2021; 11(5): 544 doi: 10.1016/j.jceh.2021.01.004
|
| 20 |
Sarah Poetter-Lang, Katharina Staufer, Pascal Baltzer, Dietmar Tamandl, Dina Muin, Nina Bastati, Emina Halilbasic, Jacqueline C. Hodge, Michael Trauner, Lili Kazemi-Shirazi, Ahmed Ba-Ssalamah. The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study. European Radiology 2019; 29(2): 1048 doi: 10.1007/s00330-018-5650-5
|
| 21 |
Salah Abdalrazak Alshehade, Raghdaa Hamdan Al Zarzour, Michael Mathai, Nelli Giribabu, Atefehalsadat Seyedan, Gurjeet Kaur, Fouad Saleih Resq Al-Suede, Amin Malik Shah Abdul Majid, Vikneswaran Murugaiyah, Hassan Almoustafa, Mohammed Abdullah Alshawsh. Orthosiphon aristatus (Blume) Miq Alleviates Non-Alcoholic Fatty Liver Disease via Antioxidant Activities in C57BL/6 Obese Mice and Palmitic–Oleic Acid-Induced Steatosis in HepG2 Cells. Pharmaceuticals 2023; 16(1): 109 doi: 10.3390/ph16010109
|
| 22 |
Xiaobao Gong, Tianju Li, Rongzhen Wan, Lin Sha. Cordycepin attenuates high-fat diet-induced non-alcoholic fatty liver disease via down-regulation of lipid metabolism and inflammatory responses. International Immunopharmacology 2021; 91: 107173 doi: 10.1016/j.intimp.2020.107173
|
| 23 |
Yu Yan, Xun Wu, Pengcheng Wang, Songyang Zhang, Lulu Sun, Yang Zhao, GuangYi Zeng, Bo Liu, Guoheng Xu, Huiying Liu, Lei Wang, Xian Wang, Changtao Jiang. Homocysteine promotes hepatic steatosis by activating the adipocyte lipolysis in a HIF1α-ERO1α-dependent oxidative stress manner. Redox Biology 2020; 37: 101742 doi: 10.1016/j.redox.2020.101742
|
| 24 |
Naveen M. Kulkarni, Alice Fung, Avinash R. Kambadakone, Benjamin M. Yeh. Computed Tomography Techniques, Protocols, Advancements, and Future Directions in Liver Diseases. Magnetic Resonance Imaging Clinics of North America 2021; 29(3): 305 doi: 10.1016/j.mric.2021.05.002
|
| 25 |
Li Zeng, Fangwei Zhong, Zhiliang Chen, Gengxi Li, Qi Zhu. Polygonatum sibiricum polysaccharides protect against obesity and non-alcoholic fatty liver disease in rats fed a high-fat diet. Food Science and Human Wellness 2022; 11(4): 1045 doi: 10.1016/j.fshw.2022.03.031
|
| 26 |
O. Yu. Filippova.
LIPID METABOLISM FEATURES IN PATIENTS WITH THE COMBINATION OF NON-ALCOHOLIC STEATOHEPATITIS AND ITS CORRECTION
. World of Medicine and Biology 2019; 15(70): 172 doi: 10.26724/2079-8334-2019-4-70-172-177
|
| 27 |
Andreas Teufel, Andreas Geier, Christoph Sarrazin, Jörn M. Schattenberg, Achim Kautz, Rebecca Dorner, Jan Kramer, Katrin Jerysiak, Theodor Baars, Bastian Hönscheid, Dirk Müller-Wieland, Siegbert Rossol, Christian Trautwein, Frank Tacke, Ali Canbay. Intersektorales Management von Patienten mit unklarer Leberwerterhöhung und nichtalkoholischer Fettlebererkrankung (NAFLD). Zeitschrift für Gastroenterologie 2023; 61(08): 1028 doi: 10.1055/a-1957-5671
|
| 28 |
William S. Blaner. Vitamin A signaling and homeostasis in obesity, diabetes, and metabolic disorders. Pharmacology & Therapeutics 2019; 197: 153 doi: 10.1016/j.pharmthera.2019.01.006
|
| 29 |
Hyo-Kyoung Choi, Eun Ju Shin, Su Jin Park, Haeng Jeon Hur, Jae Ho Park, Min-Yu Chung, Myung Sunny Kim, Jin-Taek Hwang. Ethanol Extract of Capsella bursa-pastoris Improves Hepatic Steatosis Through Inhibition of Histone Acetyltransferase Activity. Journal of Medicinal Food 2017; 20(3): 251 doi: 10.1089/jmf.2016.3877
|
| 30 |
Viola Mönkemöller, Hong Mao, Wolfgang Hübner, Gianina Dumitriu, Peter Heimann, Gahl Levy, Thomas Huser, Barbara Kaltschmidt, Christian Kaltschmidt, Cristina I. Øie. Primary rat LSECs preserve their characteristic phenotype after cryopreservation. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32103-z
|
| 31 |
Jin Chen, Yanping Hao, Ping Xu, Dongxue Bian, Liang Han, Xudong Wu, Zhengjie Zhuang, Jianhua Wang, Yan Luo. CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease. Biochemical and Biophysical Research Communications 2023; 667: 120 doi: 10.1016/j.bbrc.2023.05.027
|
| 32 |
Kairui Tang, Yuanjun Deng, Chuiyang Zheng, Huan Nie, Maoxing Pan, Runsen Chen, Jiqian Xie, Qinhe Yang, Yupei Zhang. Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/9701285
|
| 33 |
Caroline D. Veloso, Getachew D. Belew, Luciana L. Ferreira, Luís F. Grilo, John G. Jones, Piero Portincasa, Vilma A. Sardão, Paulo J. Oliveira. A Mitochondrial Approach to Cardiovascular Risk and Disease. Current Pharmaceutical Design 2019; 25(29): 3175 doi: 10.2174/1389203720666190830163735
|
| 34 |
Isabelle Arruda Barbosa, Eloá Mangabeira Santos, Alanna Fernandes Paraíso, Pablo Vinicyus Ferreira Chagas, Luís Paulo Oliveira, João Marcus Oliveira Andrade, Lucyana Conceição Farias, Bruna Mara Aparecida de Carvalho, Alfredo Maurício Batista de Paula, André Luiz Sena Guimarães, Sérgio Henrique Sousa Santos. Liraglutide alters hepatic metabolism in high-fat fed obese mice: A bioinformatic prediction and functional analysis. Meta Gene 2019; 20: 100553 doi: 10.1016/j.mgene.2019.100553
|
| 35 |
Rishi Philip Mathew, Sudhakar K Venkatesh. Imaging diffuse liver disease. Applied Radiology 2019; : 13 doi: 10.37549/AR2604
|
| 36 |
Abdallah A. Elsawy, Hossam Hodeib, Ahmed F. Selim, Mohamed E. Sarhan, Ahmed A. Elhadidy, Heba M. Sameir, Amal Selim, Mohamed A. Tawfik. The possible association between blood level of free cholesterol and the severity of steatosis in patients with nonalcoholic fatty liver disease. Tanta Medical Journal 2023; 51(1): 34 doi: 10.4103/tmj.tmj_23_22
|
| 37 |
Yasmina Filali-Mouncef, Catherine Hunter, Federica Roccio, Stavroula Zagkou, Nicolas Dupont, Charlotte Primard, Tassula Proikas-Cezanne, Fulvio Reggiori. The ménage à trois of autophagy, lipid droplets and liver disease. Autophagy 2022; 18(1): 50 doi: 10.1080/15548627.2021.1895658
|
| 38 |
Yang Zou, Meng Yu, Guotai Sheng. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01326-3
|
| 39 |
Raghu Ramanathan, Ahmad Hassan Ali, Jamal A. Ibdah. Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2022; 23(13): 7280 doi: 10.3390/ijms23137280
|
| 40 |
Ammar Salehi-sahlabadi, Elham Mirfazli, Farshad Teymoori, Sajjad Roosta, Amin Mokari, Mina Azadi, Azita Hekmatdoost. The Association Between Dietary Intake of Sodium, Potassium, and Na. International Journal of Preventive Medicine 2021; 12(1): 179 doi: 10.4103/ijpvm.IJPVM_343_20
|
| 41 |
Hyo-Joon Yang, Yoosoo Chang, Soo-Kyung Park, Yoon Suk Jung, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Seungho Ryu, Chong Il Sohn. Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis. Digestive Diseases and Sciences 2017; 62(12): 3605 doi: 10.1007/s10620-017-4805-6
|
| 42 |
N.M. Bazhenova . THE STATE OF PLATELET HEMOSTASIS IN PATIENTS WITH HYPERTENSIVE DISEASE COMBINED WITH NON-ALCOHOLIC FAT LIVER DISEASE. Medical Science of Ukraine (MSU) 2021; 17(2): 47 doi: 10.32345/2664-4738.2.2021.07
|
| 43 |
Ai Tsuji, Sayuri Yoshikawa, Yuka Ikeda, Kurumi Taniguchi, Haruka Sawamura, Sae Morikawa, Moeka Nakashima, Tomoko Asai, Satoru Matsuda. Tactics with Prebiotics for the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease via the Improvement of Mitophagy. International Journal of Molecular Sciences 2023; 24(6): 5465 doi: 10.3390/ijms24065465
|
| 44 |
Shailaja Rao, Mallesh Kurakula, Nagarjuna Mamidipalli, Papireddy Tiyyagura, Bhaumik Patel, Ravi Manne. Pharmacological Exploration of Phenolic Compound: Raspberry Ketone—Update 2020. Plants 2021; 10(7): 1323 doi: 10.3390/plants10071323
|
| 45 |
H ELKATTAWY, D MAHMOUD ABDELMONEM ELSHERBINI, H ALI EBRAHIM, D ABDULLAH, S AL-ZAHABY, Y NOSERY, A EL-SAYED HASSAN. Rho-Kinase Inhibition Ameliorates Non-Alcoholic Fatty Liver Disease in Type 2 Diabetic Rats. Physiological Research 2022; : 615 doi: 10.33549/physiolres.934869
|
| 46 |
Mohammad M Khan, Zaw Ali Khan, Mohsin Ali Khan. Metabolic complications of psychotropic medications in psychiatric disorders: Emerging role of <i>de novo</i> lipogenesis and therapeutic consideration. World Journal of Psychiatry 2024; 14(6): 767-783 doi: 10.5498/wjp.v14.i6.767
|
| 47 |
Maria Felicia Faienza, Ilaria Farella, Mohamad Khalil, Piero Portincasa. Converging Pathways between Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) and Diabetes in Children. International Journal of Molecular Sciences 2024; 25(18): 9924 doi: 10.3390/ijms25189924
|
| 48 |
Alessio Carmignani, Matteo Battaglini, Martina Bartolucci, Andrea Petretto, Mirko Prato, Gianni Ciofani. Polydopamine nanoparticles as a non-pharmaceutical tool in the treatment of fatty liver disease. Materials & Design 2024; 239: 112825 doi: 10.1016/j.matdes.2024.112825
|
| 49 |
Wiramon Rungratanawanich, Karli Rae LeFort, Young‐Eun Cho, Xiaoling Li, Byoung‐Joon Song. Melatonin Prevents Thioacetamide–Induced Gut Leakiness and Liver Fibrosis Through the Gut–Liver Axis via Modulating Sirt1‐Related Deacetylation of Gut Junctional Complex and Hepatic Proteins. Journal of Pineal Research 2024; 76(6) doi: 10.1111/jpi.13007
|
| 50 |
Matteo Donadon, Andrea Fontana, Angela Palmisano, Luca Viganò, Fabio Procopio, Matteo Cimino, Daniele Del Fabbro, Guido Torzilli. Individualized risk estimation for postoperative morbidity after hepatectomy: the Humanitas score. HPB 2017; 19(10): 910 doi: 10.1016/j.hpb.2017.06.009
|
| 51 |
Aleksandra Kołota, Dominika Głąbska. Dietary Intake of Milk Thistle Seeds as a Source of Silymarin and Its Influence on the Lipid Parameters in Nonalcoholic Fatty Liver Disease Patients. Applied Sciences 2021; 11(13): 5836 doi: 10.3390/app11135836
|
| 52 |
Elena Azzini, Lorenzo Barnaba, Donatella Ciarapica, Angela Polito. Micronutrients and Plant Food Bioactive Compounds Against Obesity
Related Diseases. Endocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23(3): 316 doi: 10.2174/1871530322666220903143820
|
| 53 |
Hee-Seop Lee, Sung-Jin Lee, Heui-Jong Yu, Jin-Hyup Lee, Hong-Yon Cho. Fermentation with Lactobacillus enhances the preventive effect of garlic extract on high fat diet-induced hepatic steatosis in mice. Journal of Functional Foods 2017; 30: 125 doi: 10.1016/j.jff.2016.12.043
|
| 54 |
Ana Isabel Álvarez-Mercado, Miguel Navarro-Oliveros, Cándido Robles-Sánchez, Julio Plaza-Díaz, María José Sáez-Lara, Sergio Muñoz-Quezada, Luis Fontana, Francisco Abadía-Molina. Microbial Population Changes and Their Relationship with Human Health and Disease. Microorganisms 2019; 7(3): 68 doi: 10.3390/microorganisms7030068
|
| 55 |
Ahmed Ba‐Ssalamah, Nina Bastati, Andreas Wibmer, Romana Fragner, Jacqueline C. Hodge, Michael Trauner, Christian J. Herold, Mustafa R. Bashir, Bernard E. Van Beers. Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?. Journal of Magnetic Resonance Imaging 2017; 45(3): 646 doi: 10.1002/jmri.25518
|
| 56 |
Yu Sato, Akiomi Yoshihisa, Yuki Kanno, Shunsuke Watanabe, Tetsuro Yokokawa, Satoshi Abe, Tomofumi Misaka, Takamasa Sato, Satoshi Suzuki, Masayoshi Oikawa, Atsushi Kobayashi, Takayoshi Yamaki, Hiroyuki Kunii, Kazuhiko Nakazato, Shu-ichi Saitoh, Yasuchika Takeishi. Liver stiffness assessed by Fibrosis-4 index predicts mortality in patients with heart failure. Open Heart 2017; 4(1): e000598 doi: 10.1136/openhrt-2017-000598
|
| 57 |
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, Gilaad G. Kaplan, Abdel-Aziz Shaheen. Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review. Nutrients 2022; 14(21): 4556 doi: 10.3390/nu14214556
|
| 58 |
Seyedeh Neda Mousavi, Elham Hosseini, Mir Saeed Seyed Dorraji, Shima Sheikh Mohammadi, Zeinab Pourmansouri, Mohammad Hossein Rasoulifard, Masumeh Doosti, Hossein Chiti. Synthesis of a green bigel using cottonseed oil/cannabis oil/alginate/ferula gum for quercetin release: Synergistic effects for treating infertility in rats. International Journal of Biological Macromolecules 2021; 177: 157 doi: 10.1016/j.ijbiomac.2021.02.121
|
| 59 |
Marion Adam, Hanna Heikelä, Cyril Sobolewski, Dorothea Portius, Jenni Mäki-Jouppila, Arfa Mehmood, Prem Adhikari, Irene Esposito, Laura L. Elo, Fu-Ping Zhang, Suvi T. Ruohonen, Leena Strauss, Michelangelo Foti, Matti Poutanen. Hydroxysteroid (17β) dehydrogenase 13 deficiency triggers hepatic steatosis and inflammation in mice. The FASEB Journal 2018; 32(6): 3434 doi: 10.1096/fj.201700914R
|
| 60 |
Natalia Zhelezniakova, Iryna Tverezovska. Diagnostic and prognostic value of selenium and Selenoprotein P in patients with comorbid course of nonalcoholic fatty liver disease and arterial hypertension. Medicinski casopis 2022; 56(2): 68 doi: 10.5937/mckg56-36421
|
| 61 |
Anastasia Asimakopoulou, Sabine Weiskirchen, Ralf Weiskirchen. Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy. Frontiers in Physiology 2016; 7 doi: 10.3389/fphys.2016.00430
|
| 62 |
Jiwon Park, Wooju Jeong, Chahyeon Yun, Hail Kim, Chang-Myung Oh. Serotonergic Regulation of Hepatic Energy Metabolism. Endocrinology and Metabolism 2021; 36(6): 1151 doi: 10.3803/EnM.2021.1331
|
| 63 |
Avilene Rodríguez-Lara, Ascensión Rueda-Robles, María José Sáez-Lara, Julio Plaza-Diaz, Ana I. Álvarez-Mercado. From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players. Pathogens 2023; 12(7): 940 doi: 10.3390/pathogens12070940
|
| 64 |
Matthew L. Holzner, Sander Florman, Myron E. Schwartz, Parissa Tabrizian. Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma. HPB 2022; 24(4): 470 doi: 10.1016/j.hpb.2021.08.943
|
| 65 |
O. M. Drapkina, A. V. Kontsevaya, A. M. Kalinina, S. N. Avdeev, M. V. Agaltsov, L. I. Alekseeva, I. I. Almazova, E. Yu. Andreenko, D. N. Antipushina, Yu. A. Balanova, S. A. Berns, A. V. Budnevsky, V. V. Gainitdinova, A. A. Garanin, V. M. Gorbunov, A. Yu. Gorshkov, E. A. Grigorenko, B. Yu. Jonova, L. Yu. Drozdova, I. V. Druk, S. O. Eliashevich, M. S. Eliseev, G. Zh. Zharylkasynova, S. A. Zabrovskaya, A. E. Imaeva, U. K. Kamilova, A. D. Kaprin, Zh. D. Kobalava, D. V. Korsunsky, O. V. Kulikova, A. S. Kurekhyan, N. P. Kutishenko, E. A. Lavrenova, M. V. Lopatina, Yu. V. Lukina, M. M. Lukyanov, E. O. Lyusina, M. N. Mamedov, B. U. Mardanov, Yu. V. Mareev, S. Yu. Martsevich, N. P. Mitkovskaya, R. P. Myasnikov, D. V. Nebieridze, S. A. Orlov, K. G. Pereverzeva, O. E. Popovkina, V. I. Potievskaya, I. A. Skripnikova, M. I. Smirnova, T. M. Sooronbaev, N. V. Toroptsova, Zh. V. Khailova, V. E. Khoronenko, M. G. Chashchin, T. A. Chernik, S. A. Shalnova, M. M. Shapovalova, R. N. Shepel, A. F. Sheptulina, V. N. Shishkova, R. U. Yuldashova, I. S. Yavelov, S. S. Yakushin. Comorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines. Cardiovascular Therapy and Prevention 2024; 23(3): 3696 doi: 10.15829/1728-8800-2024-3996
|
| 66 |
Jangho Lee, Ji-Hye Song, Min-Yu Chung, Jin-Hyuk Lee, Tae-Gyu Nam, Jae Ho Park, Jin-Taek Hwang, Hyo-Kyoung Choi. 3,4-dihydroxytoluene, a metabolite of rutin, suppresses the progression of nonalcoholic fatty liver disease in mice by inhibiting p300 histone acetyltransferase activity. Acta Pharmacologica Sinica 2021; 42(9): 1449 doi: 10.1038/s41401-020-00571-7
|
| 67 |
Moritz Peiseler, Frank Tacke. Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma. Cancers 2021; 13(4): 730 doi: 10.3390/cancers13040730
|
| 68 |
Shahinul Alam. Past, Present, and Future of Hepatitis B and Fatty Liver in Bangladesh. Gastroenterology & Hepatology: Open Access 2017; 6(3) doi: 10.15406/ghoa.2017.06.00197
|
| 69 |
Yu Yang, Yu Zhao, Wenzhen Li, Yuyao Wu, Xin Wang, Yijie Wang, Tingmei Liu, Tinghong Ye, Yongmei Xie, Zhiqiang Cheng, Jun He, Peng Bai, Yiwen Zhang, Liang Ouyang. Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment. European Journal of Medicinal Chemistry 2020; 197: 112311 doi: 10.1016/j.ejmech.2020.112311
|
| 70 |
Rashida Ginwala, Raina Bhavsar, De Gaulle I. Chigbu, Pooja Jain, Zafar K. Khan. Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin. Antioxidants 2019; 8(2): 35 doi: 10.3390/antiox8020035
|
| 71 |
Mohammad Yassin Zamanian, Mehraveh Sadeghi Ivraghi, Lusine G. Khachatryan, Diana E. Vadiyan, Hanie Yavarpour Bali, Maryam Golmohammadi. A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammation. Food Science & Nutrition 2023; 11(12): 7485 doi: 10.1002/fsn3.3713
|
| 72 |
Tian-Wen Ni, Tian-Tian Han, Ya-Ru Li, Chang Zhang, Nan Qin, Yin-Song Wang, Hong-Quan Duan, Ying Chen, Xiao-Chuan Duan. The isoxazole based flavonoid derivative 1 ameliorates non-alcoholic fatty liver disease in high-fat diet-induced obese mice by regulating lipid metabolism and inflammatory responses. Phytochemistry Letters 2022; 50: 112 doi: 10.1016/j.phytol.2022.06.005
|
| 73 |
Elizabeth P. Newberry, Yan Xie, Susan M. Kennedy, Mark J. Graham, Rosanne M. Crooke, Hui Jiang, Anping Chen, Daniel S. Ory, Nicholas O. Davidson. Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice. Hepatology 2017; 65(3): 836 doi: 10.1002/hep.28941
|
| 74 |
Rafael Mayoral Monibas, Andrew M. F. Johnson, Olivia Osborn, Paqui G. Traves, Sushil K. Mahata. Distinct Hepatic Macrophage Populations in Lean and Obese Mice. Frontiers in Endocrinology 2016; 7 doi: 10.3389/fendo.2016.00152
|
| 75 |
Víctor Cortés, Nicolás Quezada, Sergio Uribe, Marco Arrese, Flavio Nervi. Effect of cholecystectomy on hepatic fat accumulation and insulin resistance in non-obese Hispanic patients: a pilot study. Lipids in Health and Disease 2017; 16(1) doi: 10.1186/s12944-017-0525-3
|
| 76 |
Eider Talavera-Urquijo, Sarai Rodríguez-Navarro, Marc Beisani, Maria Teresa Salcedo-Allende, Aisha Chakkur, Marc Arús-Avilés, Manel Cremades, Salvador Augustin, María Martell, José M. Balibrea. Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease. Obesity Surgery 2018; 28(1): 142 doi: 10.1007/s11695-017-2805-4
|
| 77 |
Xinyue Wang, Wei Zhang, Jiale Huang, Hongwei Li, Jian Gao. The relationship between vitamin K and metabolic dysfunction-associated fatty liver disease among the United States population: National Health and Nutrition Examination Survey 2017–2018. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1086477
|
| 78 |
Liang Xu, Naoto Nagata, Mayumi Nagashimada, Fen Zhuge, Yinhua Ni, Guanliang Chen, Junzo Kamei, Hiroki Ishikawa, Yasuhiko Komatsu, Shuichi Kaneko, Tsuguhito Ota. A porcine placental extract prevents steatohepatitis by suppressing activation of macrophages and stellate cells in mice. Oncotarget 2018; 9(19): 15047 doi: 10.18632/oncotarget.24587
|
| 79 |
Yukihisa Fujinaga, Hideto Kawaratani, Daisuke Kaya, Yuki Tsuji, Takahiro Ozutsumi, Masanori Furukawa, Koh Kitagawa, Shinya Sato, Norihisa Nishimura, Yasuhiko Sawada, Hiroaki Takaya, Kosuke Kaji, Naotaka Shimozato, Kei Moriya, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(15): 5589 doi: 10.3390/ijms21155589
|
| 80 |
Wei Ma, Yingying Lu, Xin Jin, Na Lin, Lan Zhang, Yaowen Song. Targeting selective autophagy and beyond: From underlying mechanisms to potential therapies. Journal of Advanced Research 2024; 65: 297 doi: 10.1016/j.jare.2024.05.009
|
| 81 |
Kang-Yu Peng, Matthew J. Watt, Sander Rensen, Jan Willem Greve, Kevin Huynh, Kaushala S. Jayawardana, Peter J. Meikle, Ruth C.R. Meex. Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression. Journal of Lipid Research 2018; 59(10): 1977 doi: 10.1194/jlr.M085613
|
| 82 |
Weining Xie, Yan Hong, Xinrong Chen, Shujuan Wang, Fan Zhang, Xiaoling Chi. Waist-to-hip ratio and nonalcoholic fatty liver disease: a clinical observational and Mendelian randomization analysis. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1426749
|
| 83 |
A. Yu. Timakova, Yu. P. Skirdenko, M. A. Livzan, T. S. Krolevets, N. A. Nikolaev, A. V. Nelidova. Cardiovascular comorbidity in non-alcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2020; (10): 88 doi: 10.31146/1682-8658-ecg-182-10-88-95
|
| 84 |
Gashaw Hassen, Abhishek Singh, Gizeshwork Belete, Nidhi Jain, Ivonne De la Hoz, Genesis P Camacho-Leon, Nitsuh K Dargie, Keila G Carrera, Tadesse Alemu, Sharan Jhaveri, Nebiyou Solomon. Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease. Cureus 2022; doi: 10.7759/cureus.25495
|
| 85 |
Hiroaki Itoh, Naohiro Kanayama. Developmental Origins of Health and Disease (DOHaD). Advances in Experimental Medicine and Biology 2018; 1012: 29 doi: 10.1007/978-981-10-5526-3_4
|
| 86 |
Hanaa H. Gaballah, Hemat E. El‐Horany, Duaa S. Helal. Mitigative effects of the bioactive flavonol fisetin on high‐fat/high‐sucrose induced nonalcoholic fatty liver disease in rats. Journal of Cellular Biochemistry 2019; 120(8): 12762 doi: 10.1002/jcb.28544
|
| 87 |
Prabhudas Nelaturi, Sangeetha P Kademani, Vithiavathi Siva Subramanian, Sambandam Ravikumar. Increased Risk of Hypertension in Alcohol Use Disorder of alcohol-related Liver disease-A Hospital Based Case Control Study. Alcoholism Treatment Quarterly 2023; 41(1): 76 doi: 10.1080/07347324.2022.2135472
|
| 88 |
Keisuke Sawada, Hak Chung, Samir Softic, Maria E. Moreno-Fernandez, Senad Divanovic. The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease. Cell Metabolism 2023; 35(11): 1852 doi: 10.1016/j.cmet.2023.10.009
|
| 89 |
Zuzana Sumbalová, Jarmila Kucharská, Zuzana Rausová, Anna Gvozdjáková, Mária Szántová, Branislav Kura, Viliam Mojto, Ján Slezák. The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q10 Levels and Platelet Mitochondrial Bioenergetics in Patients with Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 2023; 24(15): 12477 doi: 10.3390/ijms241512477
|
| 90 |
Rosângela Passos de Jesus, Naiara Brunelle Oliveira Neiva, Thomas Thássio Rodrigues de Araújo Silva. A síndrome metabólica e suas implicações clínicas. 2018; : 139 doi: 10.7476/9786588211113.0007
|